or Try an Advanced Search...

    Technical Analysis for ATX - Amplia Therapeutics Limited

    Grade Last Price % Change Price Change
    D 0.065 1.56% 0.001
    ATX closed up 1.56 percent on Friday, April 26, 2024, on 9 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ATX trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Gilligan's Island Buy Setup Bullish Swing Setup 1.56%
    Volume Surge Other 1.56%
    Lower Bollinger Band Walk Weakness 1.56%
    New 52 Week Low Weakness 1.56%
    Wide Bands Range Expansion 1.56%
    Gapped Down Weakness 1.56%
    Older End-of-Day Signals for ATX ...

       Recent Intraday Alerts

    Alert Time
    Gilligan's Island Bullish Entry about 11 hours ago
    Rose Above Previous Day's High about 11 hours ago
    Up 1% about 11 hours ago
    Lower Bollinger Band Support 2 days ago
    Down 10% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ATX Chart by TradingView
    Basic chart:

    Profile

    Amplia Therapeutics Limited, formerly Innate Immunotherapeutics Limited, is a pharmaceutical company. The Company is engaged in research and development of immune-oncology drugs and chemotherapies to address serious unmet needs in fibrotic tumors. The Company is focused on advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis, particularly focused on pancreatic and ovarian cancer. Its initial clinical development pipeline comprises of two novel orally available small molecule FAK inhibitors: AMP945 (FAK-only) and AMP886 (FAK/FLT3/VEGFR3). FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Medicine Pharmaceutical Disease Cancer Diseases Drugs Oncology Tumor Chemotherapy Tumors Chronic Disease Fibrosis Ovarian Cancer Chronic Diseases Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis

    Is ATX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.115
    52 Week Low 0.055
    Average Volume 107,067
    200-Day Moving Average 0.082
    50-Day Moving Average 0.076
    20-Day Moving Average 0.073
    10-Day Moving Average 0.069
    Average True Range 0.005
    RSI (14) 36.31
    ADX 27.27
    +DI 19.562
    -DI 45.383
    Chandelier Exit (Long, 3 ATRs) 0.074
    Chandelier Exit (Short, 3 ATRs) 0.069
    Upper Bollinger Bands 0.087
    Lower Bollinger Band 0.059
    Percent B (%b) 0.21
    BandWidth 37.978
    MACD Line -0.004
    MACD Signal Line -0.002
    MACD Histogram -0.0014
    Fundamentals Value
    Market Cap 6.99 Million
    Num Shares 108 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -1.38
    Price-to-Sales 0.00
    Price-to-Book 2.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.065
    Resistance 3 (R3) 0.065 0.065 0.065
    Resistance 2 (R2) 0.065 0.065 0.065 0.065
    Resistance 1 (R1) 0.065 0.065 0.065 0.065 0.065
    Pivot Point 0.065 0.065 0.065 0.065 0.065
    Support 1 (S1) 0.065 0.065 0.065 0.065 0.065
    Support 2 (S2) 0.065 0.065 0.065 0.065
    Support 3 (S3) 0.065 0.065 0.065
    Support 4 (S4) 0.065